| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 100.02 | -0.99 (-0.98%) | 71.56 - 102.73 | 858.7 thousand (Below Avg) |
Market data as of 4:01PM 05/22/13. Quotes are delayed by at least 15 min.
| Open | 101.05 |
|---|---|
| Previous Close | 101.01 |
| Day's Range | 99.74 - 102.73 |
| Market Cap | 19.4B |
| Avg Volume (10 Day) | 997.9K |
| Price/Earnings (Trailing 12 Mo.) | 13.4x |
| Earnings Per Share (Trailing 12 Mo.) | 7.53 |
| Dividend Yield | 0.495 (1.98%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Pass |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Pass |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
BD Issues 2012 Sustainability Report
PR Newswire - Wednesday 05/22/2013 8:00 AM ET
BD Board Declares Dividend
PR Newswire - Tuesday 05/21/2013 11:25 AM ET
BD Announces Results For 2013 Second Fiscal Quarter
PR Newswire - Thursday 05/02/2013 6:00 AM ET
FDA Approves Second Drug in BD Simplistâ„¢ Prefilled Injectable Line of Products
PR Newswire - Tuesday 04/23/2013 8:00 AM ET
| BDX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -1.20% | |
| Net Income Growth (1yr) | 26.73% | |
| Total Debt/Equity | 0.91 | |
| LT Debt/Equity | 0.82 | |
| Earnings Yield | 7.46% | |
| Price/Sales | 2.50 |
| Company | Last | Change |
|---|---|---|
| C R Bard Inc | 105.28 | -1.34% |
| Covidien PLC | 65.25 | -0.84% |
| CareFusion Corp | 34.17 | +0.12% |
| DENTSPLY International Inc | 41.47 | -1.99% |
| Cooper Companies Inc | 107.22 | -3.40% |
Data is delayed by at least 15 min.